Edition:
United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

8.08USD
18 Apr 2019
Change (% chg)

$0.13 (+1.64%)
Prev Close
$7.95
Open
$7.95
Day's High
$8.22
Day's Low
$7.91
Volume
120,946
Avg. Vol
146,125
52-wk High
$10.42
52-wk Low
$5.76

Jaw, Ching 

Mr. Ching Jaw serves as Chief Financial Officer, Senior Vice President of the company. He served as Chief Financial Officer of North America Pharmaceuticals at Sanofi, a multinational pharmaceutical company, from 2015 to 2017 and as the Chair of the North America Regional Finance Council. From 2012 to 2015, Mr. Jaw was Chief Financial Officer for Ventana Medical Systems, a member of the Roche Group. With Genentech since 2001, and then Roche, following their acquisition of Genentech, Mr. Jaw has held a wide variety of finance positions over the years, including two years as Chief Financial Officer of Roche in Taiwan and as Head of R&D Finance. A former Army Platoon Commander and Liaison Officer in the Taiwanese Army, Mr. Jaw holds a Bachelor of Science degree in Naval Architecture from National Taiwan University, a Master of Science in Aerospace Engineering from the University of Michigan, and an M.B.A. in Finance and General Management from the University of Chicago Graduate School of Business.

Basic Compensation

Total Annual Compensation, USD 337,884
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 762,005
Fiscal Year Total, USD 1,099,890

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leonard Patrick Gage

291,926

Robert Blum

2,867,840

Ching Jaw

1,099,890

Fady Malik

1,219,940

Peter Roddy

--

David Cragg

388,209
As Of  31 Dec 2017